X-16620284-C-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_175859.3(CTPS2):c.1442G>A(p.Arg481Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000417 in 1,200,282 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000037 ( 0 hom. 1 hem. )
Consequence
CTPS2
NM_175859.3 missense
NM_175859.3 missense
Scores
11
5
1
Clinical Significance
Conservation
PhyloP100: 4.49
Genes affected
CTPS2 (HGNC:2520): (CTP synthase 2) The protein encoded by this gene catalyzes the formation of CTP from UTP with the concomitant deamination of glutamine to glutamate. This protein is the rate-limiting enzyme in the synthesis of cytosine nucleotides, which play an important role in various metabolic processes and provide the precursors necessary for the synthesis of RNA and DNA. Cancer cells that exhibit increased cell proliferation also exhibit an increased activity of this encoded protein. Thus, this protein is an attractive target for selective chemotherapy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.982
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTPS2 | NM_175859.3 | c.1442G>A | p.Arg481Gln | missense_variant | 15/19 | ENST00000359276.9 | NP_787055.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTPS2 | ENST00000359276.9 | c.1442G>A | p.Arg481Gln | missense_variant | 15/19 | 1 | NM_175859.3 | ENSP00000352222 | P1 | |
CTPS2 | ENST00000380241.7 | c.1442G>A | p.Arg481Gln | missense_variant | 15/19 | 1 | ENSP00000369590 | P1 | ||
CTPS2 | ENST00000443824.5 | c.1442G>A | p.Arg481Gln | missense_variant | 15/19 | 2 | ENSP00000401264 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000898 AC: 1AN: 111417Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33581
GnomAD3 genomes
AF:
AC:
1
AN:
111417
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33581
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000110 AC: 2AN: 181103Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65601
GnomAD3 exomes
AF:
AC:
2
AN:
181103
Hom.:
AF XY:
AC XY:
0
AN XY:
65601
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000367 AC: 4AN: 1088865Hom.: 0 Cov.: 26 AF XY: 0.00000282 AC XY: 1AN XY: 354921
GnomAD4 exome
AF:
AC:
4
AN:
1088865
Hom.:
Cov.:
26
AF XY:
AC XY:
1
AN XY:
354921
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000898 AC: 1AN: 111417Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33581
GnomAD4 genome
AF:
AC:
1
AN:
111417
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33581
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.1442G>A (p.R481Q) alteration is located in exon 15 (coding exon 14) of the CTPS2 gene. This alteration results from a G to A substitution at nucleotide position 1442, causing the arginine (R) at amino acid position 481 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;D;D
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;.;.
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;H;H
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;D
Vest4
MutPred
Loss of catalytic residue at N485 (P = 0.0999);Loss of catalytic residue at N485 (P = 0.0999);Loss of catalytic residue at N485 (P = 0.0999);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at